Think About Hemoglobinopathies Orna Steinberg Shemer MD Msc and Hannah Tamary MD

Total Page:16

File Type:pdf, Size:1020Kb

Think About Hemoglobinopathies Orna Steinberg Shemer MD Msc and Hannah Tamary MD IMAJ • VOL 16 • DeceMber 2014 EDITORIALS Think about Hemoglobinopathies Orna Steinberg Shemer MD MSc and Hannah Tamary MD Department of Hematology-Oncology, Schneider Children’s Medical Center of Israel, Petah Tikva, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel senting with dyspnea, who was eventually arterial blood was later described [6]. Low KEY WORDS: Titusville hemoglobin, diagnosed with Titusville hemoglobin- oxygen affinity hemoglobinopathies can hemoglobinopathies, cyanosis, low opathy. Hb Titusville was first described also cause a mild anemia, as was shown oxygen affinity hemoglobin by Schneider et al. in 1975 [3]. An addi- in a murine model of Hb Titusville [7]. In IMAJ 2014; 16: 785–786 tional two families with Hb Titusville were the first case described by Schneider et al. described almost two decades later [4,5]. [3], no cyanosis was detected, and indeed The clinical presentation varied between most cases are asymptomatic. The patient low oxygen saturation that was clinically described here by Marcus and colleagues asymptomatic, dyspnea and peripheral [2] probably had contributing factors, such emoglobin (Hb) is one of the most cyanosis. A Scandinavian patient who pre- as heavy smoking, which exacerbated the H studied human structures, and nu- sented with shortness of breath, low oxy- clinical presentation. merous point mutations have been dis- gen saturation measured by pulse oxime- Hb Titusville results from a point muta- covered in the globin genes. Mutations try, low oxygen saturation in arterial blood, tion causing a G to A change at codon 94 in leading to a decrease in the alpha or beta but normal partial pressure of oxygen in the alpha globin gene, leading to a change globin protein levels will result in thalas- semia; however, many point mutations Figure 1. A induce clinical consequences due to al- [A] The hemoglobin tered hemoglobin function; the most well- molecule is a tetramer known example is sickle cell hemoglo- of two alpha globin and bin. Other hemoglobinopathies can be two beta globin chains. Normally, there is an divided into a few types: equilibrium between • High oxygen affinity hemoglobinopa- oxyhemoglobin and thies causing erythrocytosis deoxyhemoglobin. In Hb • Low oxygen affinity Hb mutants. These Titusville, as well as in hemoglobinopathies can cause dyspnea Hb Kansas and Hb Beth or cyanosis, especially when the oxygen Israel, the interaction between alpha1 and dissociation curve is shifted extremely beta2 is disrupted, to the right and when the variant hemo- and the equilibrium globin is abundant is shifted towards the • M hemoglobins causing pseudocya- deoxyhemoglobin state nosis. [B] Oxygen dissociation curves B 100 Physiologically, a steady state exists of normal and low oxygen affinity hemoglobin. “Normal” represents between the oxygenated hemoglobin, 80 also called the R (relaxed binding) state the oxygen dissociation curve for normal adult hemoglobin, and “Low and deoxyhemoglobin, called the T (tight Oxygen Affinity” represents the mildly 60 binding) state, as shown in Figure 1A. right shifted oxygen dissociation This steady state is influenced by the levels curve found in disorders causing low Saturation 40 of 2,3-DPG and CO, pH, and the partial oxygen affinity, such as Hb Titusville pressure of oxygen. Some point mutations 20 in any of the globin genes can influence this steady state [1]. 0 0 10 20 30 40 50 60 70 80 90 100 In this issue of IMAJ, Marcus et al. [2] pO2 describe the case of a young patient pre- 785 EDITORIALS IMAJ • VOL 16 • DeceMber 2014 from aspartic acid to aspargine. This site is firmed by DNA sequencing. A bedside References involved in the contact area between alpha1 test that can rule out the presence of met- 1. Steinberg MH, Nagel RL. Unstable hemoglobin, hemoglobins with altered oxygen affinity, hemo- and beta2 globins. The effect manifests as hemoglobin, sulfhemoglobin and hemo- globin M, and other variants of clinical and a stabilization of the T state and lowering globin M can be performed by exposing biological interest. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, eds. Disorders of Hemo- the affinity of the hemoglobin to oxygen the blood of the patient to oxygen. In globin: Genetics, Pathophysiology and Clinical Man- [Figure 1A]. Interestingly, mutations in low oxygen affinity hemoglobinopathies, agement. Cambridge, UK: Cambridge University the beta globin, involving the same contact blood will turn from purple to bright red Press, 2009: 589-606. 2. Marcus R, Shiloh E, Mizrahi A, Gerah-Yehoshua O, area, have also been described, including upon exposure to oxygen, while the color Rapoport MJ. Titusville hemoglobinopathy pres- Hb Kansas [8] and Hb Beth Israel [9], both will not change in methemoglobinemia, enting as new-onset dyspnea in a young soldier. involving residue 102 of the beta globin. sulfhemoglobinemia and hemoglobin M IMAJ 2014; 16: 799-800. 3. Schneider RG, Atkins RJ, Hosty TS, et al. Asn102, in the beta globin, is connected disease. This test cannot, however, rule Haemoglobin Titusville: alpha94 Asp replaced by to asp94 in the alpha globin by a hydrogen out cardiopulmonary diseases that will Asn. A new haemoglobin with a lowered affinity bond. Thus, Hb Kansas, Hb Beth Israel and give the same effect. for oxygen. Biochim Biophys Acta 1975; 400: 365-73. 4. Luo HY, Irving I, Prior J, et al. Hemoglobin Hb Titusville all cause an interruption to In summary, low affinity hemoglo- Titusville, a low oxygen affinity variant hemoglobin, the alpha1-beta2 interface. Similarly, in Hb bin variants are usually benign, caus- in a family of Northern European background. F-Sarajevo, amino acid 102 of the gamma ing no or mild symptoms. However, Am J Hematol 2004; 77: 384-6. 5. Deyell R, Jackson S, Spier S, Le D, Poon MC. globin is involved [10], leading to cyanosis they should be considered in the dif- Low oxygen saturation by pulse oximetry may be appearing early in life and subsiding after ferential diagnosis of any patient with associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville. J Pediatr Hematol the neonatal period. All of the described unexplained low oxygen saturation, Oncol 2006; 28: 100-2. cases of Hb Titusville are heterozygous to dyspnea or cyanosis, especially when 6. Avellan-Hietanen H, Aittomaki J, Ekroos H, et al. the mutation, and no known homozygotes there is no evidence of cardiopulmonary Decreased oxygen saturation as a result of haemo- globin Titusville. Clin Respir J 2008; 2: 242-4. have been found as this is most likely a abnormalities. Correct diagnosis of low 7. Shirasawa T, Izumizaki M, Suzuki Y, et al. Oxygen lethal defect. oxygen affinity hemoglobinopathies is affinity of hemoglobin regulates O2 consumption, In Hb Titusville, as in other hemoglo- important, as it can eliminate the need metabolism, and physical activity. J Biol Chem 2003; 278: 5035-43. binopathies causing low oxygen affinity, for an expensive and invasive workup 8. Bonaventura J, Riggs A. Hemglobin Kansas, a the oxygen dissociation curve is shifted and is relatively simple, when these human hemoglobin with a neutral amino acid to the right [Figure 1B] and the oxygen abnormalities are properly considered substitution and an abnormal oxygen equilibrium. J Biol Chem 1968; 243: 980-91. extraction to the tissues is enhanced [7]. in the differential diagnosis. 9. Nagel RL, Lynfield J, Johnson J, Landau L, Bookchin The p50 of Hb Titusville is higher than RM, Harris MB. Hemoglobin Beth Israel. A mutant normal. Oxygen saturation measured by causing clinically apparent cyanosis. N Engl J Med Correspondence 1976; 295: 125-30. Dr. H. Tamary pulse oximetry is low; however, the partial 10. Zimmermann-Baer U, Capalo R, Dutly F, et al. pressure of oxygen in the arterial blood Head, Hematology Unit, Schneider Children’s Neonatal cyanosis due to a new (G)γ-globin variant Medical Center of Israel, Petah Tikva 49202, Israel causing low oxygen affinity: Hb F-Sarajevo [(G) is normal. The diagnosis can be made Phone: (972-3) 925-3669 γ102(G4)Asn→Thr, AAC>ACC]. Hemoglobin by hemoglobin electrophoresis and con- email: [email protected] 2012; 36: 109-13. Capsule How the common cold can worsen asthma Rhinoviruses – the main cause of the common cold – can make tion triggered IL-25 production, and blocking the IL-25 receptor asthma attacks worse. Now Beale and co-workers report that eased the increased asthma symptoms. Thus, as the cold one reason may be because rhinoviruses cause lung epithelial season approaches, blocking IL-25 may be a promising thera- cells to make the cytokine interleukin-25 (IL-25). More peutic strategy in asthmatics. IL-25 is produced in people with asthma than in those who Sci Transl Med 2014; 6: 256ral134 are healthy. In mice with allergic “asthma,” rhinovirus infec- Eitan Israeli “Patience is also a form of action” Auguste Rodin (1840-1917), French sculptor. Many of his most notable sculptures were criticized during his lifetime as they clashed with the predominant figure sculpture tradition that was decorative and formulaic. Rodin’s work departed from traditional themes of mythology and allegory, modeled the human body with realism, and celebrated individual character and physicality. He was sensitive to the controversy surrounding his work but refused to change his style. Successive works brought increasing favor from the government and the artistic community and his reputation grew. By 1900, he was a world-renowned artist. Among others, his most well-known works are The Thinker, The Kiss, and The Gates of Hell. 786 .
Recommended publications
  • Non-Commercial Use Only
    only use Non-commercial 14th International Conference on Thalassaemia and Other Haemoglobinopathies 16th TIF Conference for Patients and Parents 17-19 November 2017 • Grand Hotel Palace, Thessaloniki, Greece only use For thalassemia patients with chronic transfusional iron overload... Make a lasting impression with EXJADENon-commercial film-coated tablets The efficacy of deferasirox in a convenient once-daily film-coated tablet Please see your local Novartis representative for Full Product Information Reference: EXJADE® film-coated tablets [EU Summary of Product Characteristics]. Novartis; August 2017. Important note: Before prescribing, consult full prescribing information. iron after having achieved a satisfactory body iron level and therefore retreatment cannot be recommended. ♦ Maximum daily dose is 14 mg/kg body weight. ♦ In pediatric patients the Presentation: Dispersible tablets containing 125 mg, 250 mg or 500 mg of deferasirox. dosing should not exceed 7 mg/kg; closer monitoring of LIC and serum ferritin is essential Film-coated tablets containing 90 mg, 180 mg or 360 mg of deferasirox. to avoid overchelation; in addition to monthly serum ferritin assessments, LIC should be Indications: For the treatment of chronic iron overload due to frequent blood transfusions monitored every 3 months when serum ferritin is ≤800 micrograms/l. (≥7 ml/kg/month of packed red blood cells) in patients with beta-thalassemia major aged Dosage: Special population ♦ In moderate hepatic impairment (Child-Pugh B) dose should 6 years and older. ♦ Also indicated for the treatment of chronic iron overload due to blood not exceed 50% of the normal dose. Should not be used in severe hepatic impairment transfusions when deferoxamine therapy is contraindicated or inadequate in the following (Child-Pugh C).
    [Show full text]
  • ATSDR Case Studies in Environmental Medicine Nitrate/Nitrite Toxicity
    ATSDR Case Studies in Environmental Medicine Nitrate/Nitrite Toxicity Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM) Nitrate/Nitrite Toxicity Course: WB2342 CE Original Date: December 5, 2013 CE Expiration Date: December 5, 2015 Key • Nitrate toxicity is a preventable cause of Concepts methemoglobinemia. • Infants younger than 4 months of age are at particular risk of nitrate toxicity from contaminated well water. • The widespread use of nitrate fertilizers increases the risk of well-water contamination in rural areas. About This This educational case study document is one in a series of and Other self-instructional modules designed to increase the primary Case Studies care provider’s knowledge of hazardous substances in the in environment and to promote the adoption of medical Environmen- practices that aid in the evaluation and care of potentially tal Medicine exposed patients. The complete series of Case Studies in Environmental Medicine is located on the ATSDR Web site at URL: http://www.atsdr.cdc.gov/csem/csem.html In addition, the downloadable PDF version of this educational series and other environmental medicine materials provides content in an electronic, printable format. Acknowledgements We gratefully acknowledge the work of the medical writers, editors, and reviewers in producing this educational resource. Contributors to this version of the Case Study in Environmental Medicine are listed below. Please Note: Each content expert for this case study has indicated that there is no conflict of interest that would bias the case study content. CDC/ATSDR Author(s): Kim Gehle MD, MPH CDC/ATSDR Planners: Charlton Coles, Ph.D.; Kimberly Gehle, MD; Sharon L.
    [Show full text]
  • Hemoglobin Wayne Trait with Incidental Polycythemia
    Available online at www.annclinlabsci.org 96 Annals of Clinical & Laboratory Science, vol. 47, no. 1, 2017 Hemoglobin Wayne Trait with Incidental Polycythemia Manju Ambelil, Nghia Nguyen, Amitava Dasgupta, Semyon Risin, and Amer Wahed Department of Pathology and Laboratory Medicine, University of Texas Health Science Center- McGovern Medical School, Houston, TX, USA Abstract. Hemoglobinopathies, caused by mutations in the globin genes, are one of the most common inherited disorders. Many of the hemoglobin variants can be identified by hemoglobin analysis using conventional electrophoresis and high performance liquid chromatography; however hemoglobin DNA analysis may be necessary in other cases for confirmation. Here, we report a case of a rare alpha chain he- moglobin variant, hemoglobin Wayne, in a 47-year-old man who presented with secondary polycythemia. Capillary zone electrophoresis and high performance liquid chromatography revealed a significant amount of a hemoglobin variant, which was further confirmed by hemoglobin DNA sequencing as hemoglobin Wayne. Since the patient was not homozygous for hemoglobin Wayne, which is associated with second- ary polycythemia, the laboratory diagnosis in this case was critical in ruling out hemoglobinopathy as the etiology of his polycythemia. Key words: Hemoglobinopathies; hemoglobin Wayne; alpha globin chain variant. Introduction mean corpuscular hemoglobin of 27.1 pg. The red cell distribution width, total and differential leukocyte Hemoglobinopathies are the most common and counts, and platelets were normal. An anemia study clinically significant single-gene-inherited disorders showed a serum iron level of 127 mcg/dL, a ferritin con- [1]. These are caused by mutations in the globin centration of 239 ng/mL, an iron saturation of 42%, a total iron binding capacity of 306 mcg/dL, an unsatu- genes, resulting in quantitative and qualitative de- rated iron binding capacity of 179mcg/dL, and a vita- fects in the globin chain synthesis [2].
    [Show full text]
  • The Formation of Methemoglobin and Sulfhemoglobin During Sulfanilamide Therapy
    THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY J. S. Harris, H. O. Michel J Clin Invest. 1939;18(5):507-519. https://doi.org/10.1172/JCI101064. Research Article Find the latest version: https://jci.me/101064/pdf THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY By J. S. HARRIS AND H. 0. MICHEL (From the Departments of Pediatrics and Biochemistry, Duke University School of Medicine, Durham) (Received for publication April 8, 1939) Cyanosis almost invariably follows the admin- during the administration of sulfanilamide. Wen- istration of therapeutic amounts of sulfanilamide del (10) found spectroscopic evidence of met- (1). This cyanosis is associated with and is due hemoglobin in every blood sample containing over to a change in the color of the blood. The dark- 4 mgm. per cent sulfanilamide. Evelyn and Mal- ening of the blood is present only in the red cells loy (11) have found that all patients receiving and therefore must be ascribed to one of two sulfanilamide show methemoglobinemia, although causes, a change in the hemoglobin itself or a the intensity is usually very slight. Finally Hart- staining of the red cells with some product formed mann, Perley, and Barnett (12) found cyanosis during the metabolism of sulfanilamide. It is the associated with methemoglobinemia in almost ev- purpose of this paper to assay quantitatively the ery patient receiving over 0.1 gram sulfanilamide effect of sulfanilamide upon the first of these fac- per kilogram of body weight per day. They be- tors-that is, upon the formation of abnormal lieved that the intensity of the methemoglobinemia heme pigments.
    [Show full text]
  • A G E N D a Cibmtr Working Committee for Primary
    Not for publication or presentation A G E N D A CIBMTR WORKING COMMITTEE FOR PRIMARY IMMUNE DEFICIENCIES, INBORN ERRORS OF METABOLISM AND OTHER NON-MALIGNANT MARROW DISORDERS Honolulu, Hawaii Thursday, February 18, 2016, 12:15 – 2:15 pm Co-Chair: Paolo Anderlini, MD, MD Anderson Cancer Center, Houston, TX; Telephone: 713-745-4367; E-mail: [email protected] Co-Chair: Neena Kapoor, MD, Children’s Hospital of Los Angeles, Los Angeles, CA; Telephone: 323-361-2546; E-mail: [email protected] Co-Chair: Jaap Jan Boelens, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands; Telephone: +31 8875 54003; E-mail: [email protected] Co-Chair: Vikram Mathews, MD, DM, MBBS, Christian Medical College Hospital, Vellore, India; Telephone: +011 91 416 228 2891; E-mail: [email protected] Scientific Director: Mary Eapen, MBBS, MS, CIBMTR Statistical Center, Milwaukee, WI; Telephone: 414-805-0700; E-mail: [email protected] Statistical Ruta Brazauskas, PhD, CIBMTR Statistical Center, Milwaukee, WI; Directors: Telephone: 414-456-8687; E-mail: [email protected] Soyoung Kim, PhD, CIBMTR Statistical Center, Milwaukee Telephone: 414-955-8271; E-mail: [email protected] 1. Introduction a. Minutes and Overview Plan from February 2015 meeting (Attachment 1) 2. Accrual summary (Attachment 2) 3. Presentations, published or submitted papers a. AA12-01 Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, Radhi M, Shah AJ, Schultz KR, Wirk B, Wagner JE, Deeg HJ.
    [Show full text]
  • The Role of Nonhemoglobin Proteins and Reduced Glutathione in the Protection of Hemoglobin from Oxidation in Vitro
    The Role of Nonhemoglobin Proteins and Reduced Glutathione in the Protection of Hemoglobin from Oxidation In Vitro A. S. Hill Jr., … , G. E. Cartwright, M. M. Wintrobe J Clin Invest. 1964;43(1):17-26. https://doi.org/10.1172/JCI104889. Research Article Find the latest version: https://jci.me/104889/pdf Journal of Clinical Investigatiox Vol. 43, No. 1, 1964 The Role of Nonhemoglobin Proteins and Reduced Glutathione in the Protection of Hemoglobin from Oxidation In Vitro * A. S. HILL, JR., A. HAUT, G. E. CARTWRIGHT, AND M. M. WINTROBE (From the Department of Medicine, University of Utah College of Medicine, Salt Lake City, Utah) A deficiency of reduced glutathione in erythro- human erythrocytes by Allen and Jandl (10) led cytes of freshly shed blood (1-4) or in erythro- these authors to conclude that GSH per se pro- cytes exposed to certain chemical compounds (5) tects hemoglobin from oxidation and that no ad- has been associated with shorter red cell survival ditional factors are required; conversely, Szein- and, in most cases, with the accumulation of oxi- berg and Marks (11) found that GSH affords no dation products of hemoglobin, including methe- protection to human hemoglobin against oxidative moglobin, sulfhemoglobin, and Heinz bodies. changes. The earlier report of Foulkes and Studies of "primaquine-sensitive" hemolytic dis- Lemberg (12) that GSH might oxidize hemo- ease have emphasized as a characteristic feature globin, along with the studies by Szeinberg and an "unstable" reduced glutathione (GSH) in the Marks (11) and Allen and Jandl (10), casts red cells, attributed to limited availability of re- doubt on the applicability to humans of the con- duced TPN (TPNH), the result, in turn, of a cept (13, 14), based on studies of rat blood (7, deficiency of the enzyme, glucose-6-phosphate 8), that an adequate amount of reduced glutathi- dehydrogenase - (G6PD).
    [Show full text]
  • Hemoglobin Bart's and Alpha Thalassemia Fact Sheet
    Health Care Provider Hemoglobinopathy Fact Sheet Hemoglobin Bart’s & Alpha Thalassemia Hemoglobin Bart’s is a tetramer of gamma (fetal) globin chains seen during the newborn period. Its presence indicates that one or more of the four genes that produce alpha globin chains are dysfunctional, causing alpha thalassemia. The more alpha genes affected, the more significant the thalassemia and clinical symptoms. Alpha thalassemia occurs in individuals of all ethnic backgrounds and is one of the most common genetic diseases worldwide. However, the clinically significant forms (Hemoglobin H disease, Hemoglobin H Constant Spring, and Alpha Thalassemia Major) occur predominantly among Southeast Asians. Summarized below are the manifestations associated with the different levels of Hemoglobin Bart’s detected on the newborn screen, and recommendations for follow-up. The number of dysfunctional genes is estimated by the percentage of Bart’s seen on the newborn screen. Silent Carrier- Low Bart’s If only one alpha gene is affected, the other three genes can compensate nearly completely and only a low level of Bart’s is detected, unless hemoglobin Constant Spring is identified (see below). Levels of Bart’s below a certain percentage are not generally reported by the State Newborn Screening Program as these individuals are likely to be clinically and hematologically normal. However, a small number of babies reported as having possible alpha thalassemia trait will be silent carriers. Alpha Thalassemia or Hemoglobin Constant Spring Trait- Moderate Bart’s Alpha thalassemia trait produces a moderate level of Bart’s and typically results from the dysfunction of two alpha genes-- either due to gene deletions or a specific change in the alpha gene that produces elongated alpha globin and has a thalassemia-like effect: hemoglobin Constant Spring.
    [Show full text]
  • ICSH Guidelines for the Laboratory Diagnosis of Nonimmune Hereditary Red Cell Membrane Disorders M.-J.KING*,L.Garcßon†,J.D.HOYER‡,A.IOLASCON§,V.PICARD¶, G
    International Journal of Laboratory Hematology The Official journal of the International Society for Laboratory Hematology ORIGINAL ARTICLE INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders M.-J.KING*,L.GARCßON†,J.D.HOYER‡,A.IOLASCON§,V.PICARD¶, G. STEWART**, P. BIANCHI††, S.-H. LEE‡‡,1,A.ZANELLA††, FOR THE INTERNATIONAL COUNCIL FOR STANDARDIZATION IN HAEMATOLOGY *Membrane Biochemistry, NHS SUMMARY Blood and Transplant, Bristol, UK Introduction: Hereditary spherocytosis (HS), hereditary elliptocytosis † Laboratoire d’Hematologie, (HE), and hereditary stomatocytosis (HSt) are inherited red cell dis- Centre de Biologie Humaine, CHU d’Amiens, Amiens, France orders caused by defects in various membrane proteins. The hetero- ‡Department of Laboratory geneous clinical presentation, biochemical and genetic Medicine and Pathology, Mayo abnormalities in HS and HE have been well documented. The need Clinic Rochester, Rochester, to raise the awareness of HSt, albeit its much lower prevalence MN, USA §Department of Molecular than HS, is due to the undesirable outcome of splenectomy in these Medicine & Medical patients. Biotechnologies, University Methods: The scope of this guideline is to identify the characteristic Federico II of Naples, Naples, clinical features, the red cell parameters (including red cell mor- Italy ¶Hematologie Biologique, phology) for these red cell disorders associated, respectively, with Bicetre^ et Faculte de Pharmacie, defective cytoskeleton (HS and HE) and abnormal cation perme- AP-HP Hopital,^ Universite Paris- ability in the lipid bilayer (HSt) of the red cell. The current Sud, Le Kremlin Bicetre,^ France **Division of Medicine, screening tests for HS are described, and their limitations are University College London, highlighted.
    [Show full text]
  • Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Hindawi Case Reports in Hematology Volume 2019, Article ID 3146965, 5 pages https://doi.org/10.1155/2019/3146965 Case Report Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) Ethan Burns ,1 Kartik Anand ,1 Gonzalo Acosta ,1 Malcolm Irani,1 Betty Chung,2 Abhishek Maiti,3 Ibrahim Ibrahim,4 and Lawrence Rice 1 1Houston Methodist Hospital, Department of Medicine, 6550 Fannin St, Houston, TX 77030, USA 2Houston Methodist Hospital, Department of Pathology and Genomic Medicine, 6550 Fannin St, Houston, TX 77030, USA 3(e University of Texas MD Anderson Cancer Center, Division of Cancer Medicine, 1515 Holcombe Blvd, Houston, Texas 77030, USA 4University of Texas Southwestern, Department of Internal Medicine, Division of Hematology/Oncology, 5323 Harry Hines Blvd, Dallas, TX 75390, USA Correspondence should be addressed to Ethan Burns; [email protected] Received 2 December 2018; Revised 29 December 2018; Accepted 27 January 2019; Published 12 February 2019 Academic Editor: Ha˚kon Reikvam Copyright © 2019 Ethan Burns et al. *is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Autosplenectomy (AS) is a known complication of diseases such as sickle cell anemia, celiac disease, and inflammatory bowel disease. We report the first known case of AS due to paroxysmal nocturnal hemoglobinuria (PNH). A 24-year-old Caucasian male had evidence of hemolytic anemia at the age of 14 and was diagnosed with PNH at the age of 16. He had recurrent episodes of sepsis due to dialysis line infections from poor hygiene, and blood cultures had been positive for multiple organisms including Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pneumoniae.
    [Show full text]
  • Patient History for Hemoglobinopathy
    500 Chipeta Way Salt Lake City, UT 84108-1221 phone: 801-583-2787 | toll free: 800-242-2787 fax: 801-584-5249 | aruplab.com THIS IS NOT A TEST REQUEST FORM. Please complete and submit with the test request form or electronic packing list. PATIENT HISTORY FOR HEMOGLOBINOPATHY/THALASSEMIA TESTING Patient Name: Date of Birth: Sex: Female Male ☐ ☐ Ordering Provider: Provider’s Phone: Practice Specialty: Provider’s Fax: Genetic Counselor: Counselor Phone: Patient’s Ethnicity/Ancestry (check all that apply) African American/Black Asian Hispanic White Other: ☐ ☐ ☐ ☐ ☐ List country of origin (if known): Does the patient have symptoms? .................................................................. No Yes (check all that apply and describe) ☐ ☐ Anemia: Has iron deficiency been excluded? .......................................................................... No Yes Unknown ☐ ☐ ☐ ☐ Splenomegaly Other symptoms: ☐ ☐ Has the patient had a recent transfusion? ................... No Yes; date of transfusion: Unknown ☐ ☐ ☐ Laboratory Findings: (Indicate which testing was performed and provide results, as requested.) ☐ Hemoglobin evaluation by electrophoresis or HPLC; date performed: Hb A%: Hb C%: Hb F%: Other: Hb A2%: Hb E%: Hb S%: CBC: date performed: HGB: HCT: MCV: Reticulocyte count: ( %) ☐ Has the patient undergone previous DNA testing? ...................................................................... ☐ No Yes Unknown ☐ ☐ If yes, check the completed test(s) and provide the result or attach a copy of the laboratory report. Alpha globin deletion analysis; result: ☐ Beta globin sequencing; result: ☐ Other: ☐ Is there any relevant family history of hemoglobinopathy/thalassemia? ..................................... No Yes Unknown ☐ ☐ ☐ If yes, specify the relative's relationship to the patient: ; The relative is: a healthy carrier / affected ☐ ☐ List the gene and variant(s) identified or attach a copy of the relative's laboratory result: Check the test you intend to order.
    [Show full text]
  • Hemolytic Anemia and the Reactive Sulfhydryl Groups of the Erythrocyte Membrane
    HEMOLYTIC ANEMIA AND THE REACTIVE SULFHYDRYL GROUPS OF THE ERYTHROCYTE MEMBRANE by Erwin Peter GABOR, M.D., C.M. A thesis presented to the Faculty of Graduate Studies and Research ~n partial fulfillment of the requirements for 1 the degree of Master of Science in Experimental Medicine. McGill University Clinic and Royal Victoria Hospital, Montreal, Quebec. April, 1964. HEMOLITIC ANEMIA AND THE REACTIVE SULFHYDR!L GROUPS OF THE ER'YTHROCITE MEMBRANE by Erwin Peter Gabor ( Abstract ) Membrane sul.fhydryl ( SH) groups have been reported to be important for the maintenance of red cell integrity E, ~ ( Jacob and Jandl, 1962 ). A technique has been developed for the determination of reactive membrane sulfhydryl content in intact erythrocytes, utilizing sub­ hemolytic concentrations of p-chloromercuribenzoate (PMB). The erythrocyte membrane of 52 healthy subjects contained 2.50 - 2.85 x lo-16 moles of reactive SH groups ( mean 2.50 ·~ 0.20 ) per erythrocyte, when determined by this method. A 27-56% reduction of erythrocyte membrane SH content was observed in various conditions characterized by accelerated red cell destruction, including glucose- 6-phosphate dehydrogenase ( G6PD ) deficiency, drug-induced, auto- immune and other acquired hemolytic anemias and congenital spherocytosis. Normal membrane sulfhydryl content was found in iron deficiency anemia, pernicious anemia in relapse, and in other miscellaneous hematological conditions. Inhibition of membrane SH groups with PMB caused marked potassium leakage from the otherwise intact cells. The possible role of membrane suli'hydryl groups in the development of certain types of hemolytic anemias,and in the maintenance of active transmembrane cation transport in the erythrocyte is discussed.
    [Show full text]
  • An Unusual Case of Methemoglobinemia
    ISSN: 2639-4553 Madridge Journal of Case Reports and Studies Case Report Open Access An Unusual Case of Methemoglobinemia Devika Mishra*, Kirti N Saxena, and Bharti Wadhwa Department of Anesthesiology and Intensive care, Maulana Azad medical college and associated LokNayak hospital, New Delhi, India Article Info Abstract *Corresponding author: Methemoglobinemia is a condition in which an abnormal proportion of the iron in Devika Mishra heme moiety of the hemoglobin is oxidized to the ferric state leading to impaired Senior Resident Department of Anesthesiology and oxygen transport and anemic hypoxia and can cause tissue ischemia and death. A 21 year Intensive care old male, known case of Hansen’s disease was posted for surgicalneurolysis of ulnar Maulana Azad medical college and nerve. His surgery was already postponed once as SpO2 waslow on the operation table. associated Lok Nayak hospital, New Delhi India He then underwent complete systemic evaluation for the cause of low saturation but Phone: +91 9811889531 was found normal. On pulse oximetry it was seen that SpO2 was 91-93% on room air E-mail: [email protected] without any signs and symptoms of hypoxemia. This suggestedmethemoglobinemia due to treatment with dapsone which was being taken by the patient for treatment of Received: July 23, 2018 Hansen’s disease. The surgery was conducted uneventfully under general anesthesia. Accepted: July 26, 2018 Published: July 31, 2018 The diagnosis was confirmed by laboratory testing. Keywords: Methemoglobinemia; Dapsone. Citation: Mishra D, Saxena KN, Wadhwa B. An unusual Case of Methemoglobinemia. Madridge J Case Rep Stud. 2018; 2(1): 53-54. Introduction doi: 10.18689/mjcrs-1000113 There are many causes of low oxygen saturation (SpO2) of hemoglobin in a patient Copyright: © 2018 The Author(s).
    [Show full text]